Can a new score better predict ICU deaths? turkish study aims to find out

NCT ID NCT07300306

Recruiting now Knowledge-focused Sponsor: Marmara University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 06, 2026 · Updated 3 times

Summary

This study will check if a new scoring system called SOFA-2 can better predict which ICU patients are likely to die within 30 days, compared to the current standard. Researchers will also measure how common sepsis and septic shock are in Turkish intensive care units. About 2,500 adult ICU patients will be observed, but no experimental treatments will be given.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could give doctors a better tool to predict which ICU patients are at highest risk of dying within 30 days, helping guide care decisions.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly help patients. The new score may not prove more accurate than existing methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness infectious disease with sepsis Sepsis toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRITICAL ILLNESS ORGAN DYSFUNCTION SEPSIS SEPTIC SHOCK

Contacts and locations

Locations

Marmara University Pendik Training and Research Hospital
RECRUITING

Istanbul, 34912, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.